45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 16-19 December 2005, Washington, USA
10 February 2006. Related: Conference reports, Conference index, ICAAC 45th Washingon 2005.
- Understanding TMC114 power against resistant HIV
- New antiretroviral compounds at ICAAC: new PI brecanavir from GSK; maturation inhibitor PA-457; antiviral activity of monoclonal antibody; TNX-355 in treatment experienced patients
- Comparison of pharmacokinetics of originator and generic liquid formulations and split tablets in Malawian children
- African-Americans in ACTG 5095 had shorter time to virologic failure and grade 3/4 side effects
- Predictors of insulin resistance in first year of therapy
- Three measures confirm 144-week renal record of tenofovir
- Low rash risk with efavirenz after nevirapine rash
Abstracts from the ICAAC meeting only remain on the conference website for a few months, and are then only available through subscription.
